Viewing Study NCT00819793


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2025-12-25 @ 11:25 PM
Study NCT ID: NCT00819793
Status: COMPLETED
Last Update Posted: 2022-06-27
First Post: 2009-01-08
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Sponsor: Abbott Medical Devices
Organization:

Study Overview

Official Title: Thoratec CentriMag VAS Failure-to-Wean From Cardiopulmonary Bypass Trial
Status: COMPLETED
Status Verified Date: 2022-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help patients who have experienced heart failure during surgery and cannot be removed from cardiac bypass.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: